Herbert Smulls, 56, was put to death last night after a reprieve granted by US Supreme Court Judge Samuel Alito late Tuesday was lifted by the court.
Smulls had challenging the use of the drugs that were to be used to execute him.
After the reprieve was lifted, and before the man was executed, three other appeals were filed. The last was still pending when he was put to death, his legal team told AFP.
Smulls was on death row for the 1991 killing of a jeweler during an armed robbery. The governor of Missouri rejected his petition for a stay of execution.
Alito is the justice assigned to cases from the region of the United States that includes Missouri.
He is expected to rule soon on a similar petition from Louisiana inmate Christopher Sepulvado, due to be put to death next week.
Sepulvado is scheduled to die for fatally beating and scalding his six-year-old stepson in 1992.
Attorneys for both men maintain that the failure to reveal the identity of the pharmacy makes it impossible to know if the execution would constitute "cruel and inhumane punishment" under the Eighth Amendment of the US Constitution.
In that instance, Michael Lee Wilson, who was executed on January 9, said he could feel his whole body "burning" as he was put to death.
An expert cited by lawyers for Smulls said the same Oklahoma lab is believed to have approved drugs produced in Massachusetts allegedly responsible for an outbreak of meningitis in November 2012.
After the Missouri governor refused late Tuesday to stay the execution, lawyer Cheryl Pilate asked the Supreme Court to demand that the state divulge the name of the pharmacy that provided the drug it intends to use for the lethal injection.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
